Caprico Biotechnologies
Zhengzhou
About Caprico Biotechnologies
Caprico Biotechnologies provides flow cytometry reagents and services for basic research, clinical research, and clinical diagnostic.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Funding stage: Seed
- Last round: Seed (Jul 2024)
- Website: capricobiotech.com
- Phone: 0371-86566089
Industries & Categories
Biotechnology, Clinical Trials, Health Care
Social Profiles
Canonical: https://fsome.com/organization/caprico-biotechnologies-2435864 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.